603233.SH
DaShenLin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 18.29
−1.03%Leverage
- Debt / equity
- 0.33x
- Net debt / equity
- -0.54x
- Debt / assets
- 0.10x
- Debt / EBITDA
- 1.09x
- Net debt / EBITDA
- -1.78x
Liquidity & coverage
- Current ratio
- 0.93x
- Quick ratio
- 0.64x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -CNY 1.1B
Cash & dividend
- FCF / debt
- 1.54x
- Cash flow / debt
- 1.74x
- Dividend per share
- CNY 1.24
- Dividend yield
- 6.7%
- Dividend growth 1y
- +38.5%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026